Loading…

Elevated Ki-67 (MIB-1) expression as an independent predictor for unfavorable pathologic outcomes and biochemical recurrence after radical prostatectomy in patients with localized prostate cancer: A propensity score matched study

Ki-67 is known to be useful in estimating the fraction of proliferation tumor cells in various malignancies. We tried to investigate clinical association of Ki-67 (MIB-1) expression with the oncological outcomes in patients with localized prostate cancer (PCa) after the radical prostatectomy (RP). W...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2019-11, Vol.14 (11), p.e0224671-e0224671
Main Authors: Byun, Seok-Soo, Lee, Minseung, Hong, Sung Kyu, Lee, Hakmin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c593t-35ecf29b483afe3904495a389641a9ccc2ef36a6a2cd38a1b752f3ab33429ca73
cites cdi_FETCH-LOGICAL-c593t-35ecf29b483afe3904495a389641a9ccc2ef36a6a2cd38a1b752f3ab33429ca73
container_end_page e0224671
container_issue 11
container_start_page e0224671
container_title PloS one
container_volume 14
creator Byun, Seok-Soo
Lee, Minseung
Hong, Sung Kyu
Lee, Hakmin
description Ki-67 is known to be useful in estimating the fraction of proliferation tumor cells in various malignancies. We tried to investigate clinical association of Ki-67 (MIB-1) expression with the oncological outcomes in patients with localized prostate cancer (PCa) after the radical prostatectomy (RP). We retrospectively analyzed the data of 1,561 patients who underwent RP for localized PCa. According to the propensity score having Ki-67 expression, 183 patients with positive Ki-67 expression were matched to 549 patients without Ki-67 expression. By using multivariate Cox-proportional hazards models and logistic regression tests, the prognostic value of each variable was tested. After propensity score matching, positive Ki-67 group showed significant worse clinical characteristics and pathologic outcomes than negative Ki-67 group. The multivariate analysis showed that the Ki-67 expression was significantly associated with several adverse pathologic outcomes including higher pathologic stage (p = 0.006), higher grade group (p = 0.005), seminal vesicle invasion (p = 0.036), and positive surgical margin (p = 0.025). The group with Ki-67 expression showed significant worse biochemical recurrence-free survival (p
doi_str_mv 10.1371/journal.pone.0224671
format article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2312799179</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A605081713</galeid><doaj_id>oai_doaj_org_article_e924775e23a946f98cb0d4dffdd47986</doaj_id><sourcerecordid>A605081713</sourcerecordid><originalsourceid>FETCH-LOGICAL-c593t-35ecf29b483afe3904495a389641a9ccc2ef36a6a2cd38a1b752f3ab33429ca73</originalsourceid><addsrcrecordid>eNptU01v1DAQjRCIlsI_QGCJSznsEtuJHXNAKlWBiiIucLYm_th1lcSp7RSW_8v_wNndVi2qrNjRzJv3ZuyZoniJyyWmHL-79FMYoFuOfjDLkpCKcfyoOMSCkgUjJX185_-geBbjZVnWtGHsaXFAMROc4-aw-HvWmWtIRqOvbsE4Ov52_nGB3yLzewwmRucHBBHBgNygzWjyNiSUXdqp5AOy-ZsGC9c-QNsZNEJa-86vnEJ-Ssr3Zg7WqHVerU3vFHQoGDWFYAZlENhkAgqgt44x-JhyLpm532TBmc1lvYh-ubRGnc8g9yenegNECjJLeI9OZlPOLrq0QVH5YFAPKStqFNOkN8-LJxa6aF7sz6Pi56ezH6dfFhffP5-fnlwsVC1oWtDaKEtEWzUUrKGirCpRA20EqzAIpRQxljJgQJSmDeCW18RSaCmtiFDA6VHxesc7dj7K_QtFSSgmXAjMRUac7xDaw6Ucg-shbKQHJ7cGH1YSQnKqM9IIUnFeG0JBVMyKRrWlrrS1WldcNCxzfdirTW1vtMpXFaC7R3rfM7i1XPlryRrKKakzwfGeIPirycQkexeV6ToYjJ-2eVPKCMOz1pv_oA9Xt0etIBfgBuuzrppJ5Qkr67LBPDMeFcsHUHnpuUNyO1uX7fcCql2Ayg8fg7G3NeJSzsNwk4ych0HuhyGHvbp7P7dBN91P_wEJnAzL</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2312799179</pqid></control><display><type>article</type><title>Elevated Ki-67 (MIB-1) expression as an independent predictor for unfavorable pathologic outcomes and biochemical recurrence after radical prostatectomy in patients with localized prostate cancer: A propensity score matched study</title><source>Publicly Available Content Database</source><source>PubMed Central(OpenAccess)</source><creator>Byun, Seok-Soo ; Lee, Minseung ; Hong, Sung Kyu ; Lee, Hakmin</creator><contributor>Kim, Isaac Yi</contributor><creatorcontrib>Byun, Seok-Soo ; Lee, Minseung ; Hong, Sung Kyu ; Lee, Hakmin ; Kim, Isaac Yi</creatorcontrib><description>Ki-67 is known to be useful in estimating the fraction of proliferation tumor cells in various malignancies. We tried to investigate clinical association of Ki-67 (MIB-1) expression with the oncological outcomes in patients with localized prostate cancer (PCa) after the radical prostatectomy (RP). We retrospectively analyzed the data of 1,561 patients who underwent RP for localized PCa. According to the propensity score having Ki-67 expression, 183 patients with positive Ki-67 expression were matched to 549 patients without Ki-67 expression. By using multivariate Cox-proportional hazards models and logistic regression tests, the prognostic value of each variable was tested. After propensity score matching, positive Ki-67 group showed significant worse clinical characteristics and pathologic outcomes than negative Ki-67 group. The multivariate analysis showed that the Ki-67 expression was significantly associated with several adverse pathologic outcomes including higher pathologic stage (p = 0.006), higher grade group (p = 0.005), seminal vesicle invasion (p = 0.036), and positive surgical margin (p = 0.025). The group with Ki-67 expression showed significant worse biochemical recurrence-free survival (p&lt;0.001) than negative Ki-67 group. Subsequent multivariate Cox analyses showed that Ki-67 was independent predictor for BCR after RP (HR 1.549, 95% CI 1.187-2.021, p = 0.001). In our study, high Ki-67 expression was significantly related with adverse pathological and finally with worse biochemical recurrence-free survival. Further studies are needed to validate the prognostic value of Ki-67 more exactly in PCa patients.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0224671</identifier><identifier>PMID: 31697718</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>2-Methylisoborneol ; Aged ; Analysis ; Antigens ; Biochemistry ; Biology and Life Sciences ; Biomarkers ; Breast cancer ; Cancer patients ; Cancer research ; Cancer surgery ; Cancer therapies ; Care and treatment ; Cell proliferation ; Humans ; Kaplan-Meier Estimate ; Ki-67 Antigen - metabolism ; Male ; Medical prognosis ; Medicine and Health Sciences ; Metastasis ; Middle Aged ; Multivariate Analysis ; Neoplasm Recurrence, Local - metabolism ; Neoplasm Recurrence, Local - pathology ; Patient outcomes ; Physical Sciences ; Prognosis ; Propensity Score ; Proportional Hazards Models ; Prostate cancer ; Prostatectomy ; Prostatic Neoplasms - metabolism ; Prostatic Neoplasms - pathology ; Prostatic Neoplasms - surgery ; Radiation therapy ; Recurrence (Disease) ; Regression analysis ; Research and Analysis Methods ; Review boards ; Seminal vesicle ; Statistical models ; Surgery ; Survival ; Treatment Outcome ; Tumor cells ; Tumors ; Urological surgery ; Urology</subject><ispartof>PloS one, 2019-11, Vol.14 (11), p.e0224671-e0224671</ispartof><rights>COPYRIGHT 2019 Public Library of Science</rights><rights>2019 Byun et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2019 Byun et al 2019 Byun et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c593t-35ecf29b483afe3904495a389641a9ccc2ef36a6a2cd38a1b752f3ab33429ca73</citedby><cites>FETCH-LOGICAL-c593t-35ecf29b483afe3904495a389641a9ccc2ef36a6a2cd38a1b752f3ab33429ca73</cites><orcidid>0000-0002-1247-9958</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2312799179/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2312799179?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,25734,27905,27906,36993,36994,44571,53772,53774,74875</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31697718$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Kim, Isaac Yi</contributor><creatorcontrib>Byun, Seok-Soo</creatorcontrib><creatorcontrib>Lee, Minseung</creatorcontrib><creatorcontrib>Hong, Sung Kyu</creatorcontrib><creatorcontrib>Lee, Hakmin</creatorcontrib><title>Elevated Ki-67 (MIB-1) expression as an independent predictor for unfavorable pathologic outcomes and biochemical recurrence after radical prostatectomy in patients with localized prostate cancer: A propensity score matched study</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Ki-67 is known to be useful in estimating the fraction of proliferation tumor cells in various malignancies. We tried to investigate clinical association of Ki-67 (MIB-1) expression with the oncological outcomes in patients with localized prostate cancer (PCa) after the radical prostatectomy (RP). We retrospectively analyzed the data of 1,561 patients who underwent RP for localized PCa. According to the propensity score having Ki-67 expression, 183 patients with positive Ki-67 expression were matched to 549 patients without Ki-67 expression. By using multivariate Cox-proportional hazards models and logistic regression tests, the prognostic value of each variable was tested. After propensity score matching, positive Ki-67 group showed significant worse clinical characteristics and pathologic outcomes than negative Ki-67 group. The multivariate analysis showed that the Ki-67 expression was significantly associated with several adverse pathologic outcomes including higher pathologic stage (p = 0.006), higher grade group (p = 0.005), seminal vesicle invasion (p = 0.036), and positive surgical margin (p = 0.025). The group with Ki-67 expression showed significant worse biochemical recurrence-free survival (p&lt;0.001) than negative Ki-67 group. Subsequent multivariate Cox analyses showed that Ki-67 was independent predictor for BCR after RP (HR 1.549, 95% CI 1.187-2.021, p = 0.001). In our study, high Ki-67 expression was significantly related with adverse pathological and finally with worse biochemical recurrence-free survival. Further studies are needed to validate the prognostic value of Ki-67 more exactly in PCa patients.</description><subject>2-Methylisoborneol</subject><subject>Aged</subject><subject>Analysis</subject><subject>Antigens</subject><subject>Biochemistry</subject><subject>Biology and Life Sciences</subject><subject>Biomarkers</subject><subject>Breast cancer</subject><subject>Cancer patients</subject><subject>Cancer research</subject><subject>Cancer surgery</subject><subject>Cancer therapies</subject><subject>Care and treatment</subject><subject>Cell proliferation</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>Ki-67 Antigen - metabolism</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Medicine and Health Sciences</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Neoplasm Recurrence, Local - metabolism</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Patient outcomes</subject><subject>Physical Sciences</subject><subject>Prognosis</subject><subject>Propensity Score</subject><subject>Proportional Hazards Models</subject><subject>Prostate cancer</subject><subject>Prostatectomy</subject><subject>Prostatic Neoplasms - metabolism</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Prostatic Neoplasms - surgery</subject><subject>Radiation therapy</subject><subject>Recurrence (Disease)</subject><subject>Regression analysis</subject><subject>Research and Analysis Methods</subject><subject>Review boards</subject><subject>Seminal vesicle</subject><subject>Statistical models</subject><subject>Surgery</subject><subject>Survival</subject><subject>Treatment Outcome</subject><subject>Tumor cells</subject><subject>Tumors</subject><subject>Urological surgery</subject><subject>Urology</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptU01v1DAQjRCIlsI_QGCJSznsEtuJHXNAKlWBiiIucLYm_th1lcSp7RSW_8v_wNndVi2qrNjRzJv3ZuyZoniJyyWmHL-79FMYoFuOfjDLkpCKcfyoOMSCkgUjJX185_-geBbjZVnWtGHsaXFAMROc4-aw-HvWmWtIRqOvbsE4Ov52_nGB3yLzewwmRucHBBHBgNygzWjyNiSUXdqp5AOy-ZsGC9c-QNsZNEJa-86vnEJ-Ssr3Zg7WqHVerU3vFHQoGDWFYAZlENhkAgqgt44x-JhyLpm532TBmc1lvYh-ubRGnc8g9yenegNECjJLeI9OZlPOLrq0QVH5YFAPKStqFNOkN8-LJxa6aF7sz6Pi56ezH6dfFhffP5-fnlwsVC1oWtDaKEtEWzUUrKGirCpRA20EqzAIpRQxljJgQJSmDeCW18RSaCmtiFDA6VHxesc7dj7K_QtFSSgmXAjMRUac7xDaw6Ucg-shbKQHJ7cGH1YSQnKqM9IIUnFeG0JBVMyKRrWlrrS1WldcNCxzfdirTW1vtMpXFaC7R3rfM7i1XPlryRrKKakzwfGeIPirycQkexeV6ToYjJ-2eVPKCMOz1pv_oA9Xt0etIBfgBuuzrppJ5Qkr67LBPDMeFcsHUHnpuUNyO1uX7fcCql2Ayg8fg7G3NeJSzsNwk4ych0HuhyGHvbp7P7dBN91P_wEJnAzL</recordid><startdate>20191107</startdate><enddate>20191107</enddate><creator>Byun, Seok-Soo</creator><creator>Lee, Minseung</creator><creator>Hong, Sung Kyu</creator><creator>Lee, Hakmin</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-1247-9958</orcidid></search><sort><creationdate>20191107</creationdate><title>Elevated Ki-67 (MIB-1) expression as an independent predictor for unfavorable pathologic outcomes and biochemical recurrence after radical prostatectomy in patients with localized prostate cancer: A propensity score matched study</title><author>Byun, Seok-Soo ; Lee, Minseung ; Hong, Sung Kyu ; Lee, Hakmin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c593t-35ecf29b483afe3904495a389641a9ccc2ef36a6a2cd38a1b752f3ab33429ca73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>2-Methylisoborneol</topic><topic>Aged</topic><topic>Analysis</topic><topic>Antigens</topic><topic>Biochemistry</topic><topic>Biology and Life Sciences</topic><topic>Biomarkers</topic><topic>Breast cancer</topic><topic>Cancer patients</topic><topic>Cancer research</topic><topic>Cancer surgery</topic><topic>Cancer therapies</topic><topic>Care and treatment</topic><topic>Cell proliferation</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>Ki-67 Antigen - metabolism</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Medicine and Health Sciences</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Neoplasm Recurrence, Local - metabolism</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Patient outcomes</topic><topic>Physical Sciences</topic><topic>Prognosis</topic><topic>Propensity Score</topic><topic>Proportional Hazards Models</topic><topic>Prostate cancer</topic><topic>Prostatectomy</topic><topic>Prostatic Neoplasms - metabolism</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Prostatic Neoplasms - surgery</topic><topic>Radiation therapy</topic><topic>Recurrence (Disease)</topic><topic>Regression analysis</topic><topic>Research and Analysis Methods</topic><topic>Review boards</topic><topic>Seminal vesicle</topic><topic>Statistical models</topic><topic>Surgery</topic><topic>Survival</topic><topic>Treatment Outcome</topic><topic>Tumor cells</topic><topic>Tumors</topic><topic>Urological surgery</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Byun, Seok-Soo</creatorcontrib><creatorcontrib>Lee, Minseung</creatorcontrib><creatorcontrib>Hong, Sung Kyu</creatorcontrib><creatorcontrib>Lee, Hakmin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agriculture Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Byun, Seok-Soo</au><au>Lee, Minseung</au><au>Hong, Sung Kyu</au><au>Lee, Hakmin</au><au>Kim, Isaac Yi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Elevated Ki-67 (MIB-1) expression as an independent predictor for unfavorable pathologic outcomes and biochemical recurrence after radical prostatectomy in patients with localized prostate cancer: A propensity score matched study</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2019-11-07</date><risdate>2019</risdate><volume>14</volume><issue>11</issue><spage>e0224671</spage><epage>e0224671</epage><pages>e0224671-e0224671</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Ki-67 is known to be useful in estimating the fraction of proliferation tumor cells in various malignancies. We tried to investigate clinical association of Ki-67 (MIB-1) expression with the oncological outcomes in patients with localized prostate cancer (PCa) after the radical prostatectomy (RP). We retrospectively analyzed the data of 1,561 patients who underwent RP for localized PCa. According to the propensity score having Ki-67 expression, 183 patients with positive Ki-67 expression were matched to 549 patients without Ki-67 expression. By using multivariate Cox-proportional hazards models and logistic regression tests, the prognostic value of each variable was tested. After propensity score matching, positive Ki-67 group showed significant worse clinical characteristics and pathologic outcomes than negative Ki-67 group. The multivariate analysis showed that the Ki-67 expression was significantly associated with several adverse pathologic outcomes including higher pathologic stage (p = 0.006), higher grade group (p = 0.005), seminal vesicle invasion (p = 0.036), and positive surgical margin (p = 0.025). The group with Ki-67 expression showed significant worse biochemical recurrence-free survival (p&lt;0.001) than negative Ki-67 group. Subsequent multivariate Cox analyses showed that Ki-67 was independent predictor for BCR after RP (HR 1.549, 95% CI 1.187-2.021, p = 0.001). In our study, high Ki-67 expression was significantly related with adverse pathological and finally with worse biochemical recurrence-free survival. Further studies are needed to validate the prognostic value of Ki-67 more exactly in PCa patients.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>31697718</pmid><doi>10.1371/journal.pone.0224671</doi><orcidid>https://orcid.org/0000-0002-1247-9958</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2019-11, Vol.14 (11), p.e0224671-e0224671
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_2312799179
source Publicly Available Content Database; PubMed Central(OpenAccess)
subjects 2-Methylisoborneol
Aged
Analysis
Antigens
Biochemistry
Biology and Life Sciences
Biomarkers
Breast cancer
Cancer patients
Cancer research
Cancer surgery
Cancer therapies
Care and treatment
Cell proliferation
Humans
Kaplan-Meier Estimate
Ki-67 Antigen - metabolism
Male
Medical prognosis
Medicine and Health Sciences
Metastasis
Middle Aged
Multivariate Analysis
Neoplasm Recurrence, Local - metabolism
Neoplasm Recurrence, Local - pathology
Patient outcomes
Physical Sciences
Prognosis
Propensity Score
Proportional Hazards Models
Prostate cancer
Prostatectomy
Prostatic Neoplasms - metabolism
Prostatic Neoplasms - pathology
Prostatic Neoplasms - surgery
Radiation therapy
Recurrence (Disease)
Regression analysis
Research and Analysis Methods
Review boards
Seminal vesicle
Statistical models
Surgery
Survival
Treatment Outcome
Tumor cells
Tumors
Urological surgery
Urology
title Elevated Ki-67 (MIB-1) expression as an independent predictor for unfavorable pathologic outcomes and biochemical recurrence after radical prostatectomy in patients with localized prostate cancer: A propensity score matched study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T17%3A56%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Elevated%20Ki-67%20(MIB-1)%20expression%20as%20an%20independent%20predictor%20for%20unfavorable%20pathologic%20outcomes%20and%20biochemical%20recurrence%20after%20radical%20prostatectomy%20in%20patients%20with%20localized%20prostate%20cancer:%20A%20propensity%20score%20matched%20study&rft.jtitle=PloS%20one&rft.au=Byun,%20Seok-Soo&rft.date=2019-11-07&rft.volume=14&rft.issue=11&rft.spage=e0224671&rft.epage=e0224671&rft.pages=e0224671-e0224671&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0224671&rft_dat=%3Cgale_plos_%3EA605081713%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c593t-35ecf29b483afe3904495a389641a9ccc2ef36a6a2cd38a1b752f3ab33429ca73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2312799179&rft_id=info:pmid/31697718&rft_galeid=A605081713&rfr_iscdi=true